mRNA expression and western blotting indicated that, with the exception of LRP1 in 22Rv1, all components of the LRP1-Met-IQSEC1-ARF5/6 pathway are expressed in examined prostate cancer cell lines (Supplementary Fig. 9a, b). This evidence concerns the gene IQSEC1 and prostate cancer.